Endometrial cancer: Difference between revisions
Line 30: | Line 30: | ||
==Treatment== | ==Treatment== | ||
[[Endometrial cancer medical therapy|Medical | [[Endometrial cancer medical therapy|Medical therapy]] | [[Endometrial cancer surgery|Surgical options]] | [[Endometrial cancer primary prevention|Primary prevention]] | [[Endometrial cancer secondary prevention|Secondary prevention]] | [[Endometrial cancer cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Endometrial cancer future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Revision as of 20:24, 31 August 2015
For patient information click here
Endometrial cancer | |
An endometrial adenocarcinoma invading the uterine muscle | |
ICD-10 | C54.1 |
ICD-9 | 182 |
OMIM | 608089 |
DiseasesDB | 4252 |
MedlinePlus | 000910 |
Endometrial cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Endometrial cancer On the Web |
American Roentgen Ray Society Images of Endometrial cancer |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Endometrial adenocarcinoma; uterine adenocarcinoma; uterine cancer; adenocarcinoma - endometrium; adenocarcinoma - uterus; cancer - uterine; cancer - endometrial; uterine corpus cancer
Overview
Classification
Pathophysiology
Causes
Differentiating Endometrial Cancer from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory Findings | Chest X Rays | CT | MRI Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical therapy | Surgical options | Primary prevention | Secondary prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies